These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 29330741

  • 21. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
    Liu J, Su D, Yuan P, Ye B, Qin S, Pang Y.
    Cardiology; 2023; 148(5):457-468. PubMed ID: 37231847
    [Abstract] [Full Text] [Related]

  • 22. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z.
    BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405
    [Abstract] [Full Text] [Related]

  • 23. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
    Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
    [Abstract] [Full Text] [Related]

  • 24. Giant aneurysms: A gender-specific complication of Kawasaki disease?
    Dietz SM, Kuipers IM, Tacke CEA, Koole JCD, Hutten BA, Kuijpers TW.
    J Cardiol; 2017 Oct 31; 70(4):359-365. PubMed ID: 28325522
    [Abstract] [Full Text] [Related]

  • 25. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML, Manlhiot C, Collins TH, Chahal N, Yeung RSM, McCrindle BW.
    Int J Cardiol; 2017 Jun 01; 236():157-161. PubMed ID: 28089146
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Clin Exp Med; 2019 May 01; 19(2):173-181. PubMed ID: 30617865
    [Abstract] [Full Text] [Related]

  • 27. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr 01; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 28. [Retrospective analysis of infliximab in the treatment of Kawasaki disease].
    Xie LP, Zhao L, Chu C, He L, Liang XC, Sun SN, Zhao QM, Wang F, Cao YY, Lin YX, Zeng ZQ, Wu L, Huang GY, Liu F.
    Zhonghua Er Ke Za Zhi; 2022 Jan 02; 60(1):14-19. PubMed ID: 34986617
    [Abstract] [Full Text] [Related]

  • 29. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov 02; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 30. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Rheumatol Int; 2015 Jun 02; 35(6):1053-8. PubMed ID: 25429794
    [Abstract] [Full Text] [Related]

  • 31. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.
    Narayan HK, Lizcano A, Lam-Hine T, Ulloa-Gutierrez R, Bainto EV, Garrido-García LM, Estripeaut D, Del Aguila O, Gómez V, Faugier-Fuentes E, Miño-León G, Beltrán S, Cofré F, Chacon-Cruz E, Saltigeral-Simental P, Martínez-Medina L, Dueñas L, Luciani K, Rodríguez-Quiroz FJ, Camacho Moreno G, Viviani T, Alvarez-Olmos MI, Marques HHS, López-Medina E, Pirez MC, Tremoulet AH, Kawasaki Disease REKAMLATINA Network Study Group.
    J Pediatr; 2023 Dec 02; 263():113346. PubMed ID: 36775190
    [Abstract] [Full Text] [Related]

  • 32. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL, Luo JP, Qi YQ, Liang YG, Wang W, Gong FQ.
    Zhonghua Er Ke Za Zhi; 2013 Dec 02; 51(12):925-9. PubMed ID: 24495764
    [Abstract] [Full Text] [Related]

  • 33. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].
    Liu WQ, Xia B, Fan W, Yu Z, Lin WL, Chen L, Wang C, Liu BN, Li J, Yang J.
    Zhonghua Er Ke Za Zhi; 2022 Jun 02; 60(6):588-593. PubMed ID: 35658368
    [Abstract] [Full Text] [Related]

  • 34. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L, Salama A, Uthaman B, Kumar A, Selvan J.
    Int J Cardiol; 1999 Apr 30; 69(1):71-6. PubMed ID: 10362375
    [Abstract] [Full Text] [Related]

  • 35. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
    He XH, Zhu QL, Yuan YH, Long XD, Xia XH, Wang S, Hu C.
    Zhonghua Er Ke Za Zhi; 2021 Feb 02; 59(2):95-100. PubMed ID: 33548954
    [Abstract] [Full Text] [Related]

  • 36. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
    Zhonghua Er Ke Za Zhi; 2006 May 02; 44(5):324-8. PubMed ID: 16780705
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec 02; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 38. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 02; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 39. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 02; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 40. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
    Tajima M, Shiozawa Y, Kagawa J.
    Pediatr Cardiol; 2015 Aug 02; 36(6):1159-65. PubMed ID: 25753685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.